Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?


5 Micro and Small-Cap Biotechs Developing Stem Cell Treatments

By  +Follow August 1, 2013 8:43AM
Tickers Mentioned:

Stem cells have once again flitted through the news cycle, this time as a result of a new and growing industry that has arisen around the use of adult stem cells in cosmetic treatments that purport to both be more effective and less dangerous than traditional procedures such as the infamous and potentially toxic Botox injections.

But the scientific basis for the use of stem cells for cosmetic procedures is entirely tentative. To date, the US Food and Drug Administration has not approved any stem cell-based products for use, aside from a small number of umbilical cord blood-derived treatments for blood cancer as well as hereditary metabolic and autoimmune disorders.

Cosmetic treatments of any variety are subject to far less scrutiny than medical treatments, however, and this is what is currently allowing an increasing amount of doctors throughout the country to charge as much as $30,000 for procedures whose value are more or less unproven from the standpoint of official studies, clinical trials, and peer reviews.

Considering that so few medical products involving stem cells have been approved, a high degree of skepticism should probably be applied to any magical claims about the potential for stem cells to make one look younger, or to otherwise repair one’s perceived cosmetic iniquities. A terrifying article that appeared last December in The Scientific American suffices to support this contention.

But stem cells, whether of the adult of cord-blood variety, are believed to have regenerative properties that could repair all manner of human diseases and conditions, from cardiovascular conditions, to autoimmune diseases. The following five companies are biotechs that are working to ostensibly better the human condition through the use of stem-cell technology, and are all in the midst of clinical trials for various treatments, or on their way to beginning them

Osiris Therapeutics (OSIR) — With a market cap of $377 million, the Columbia, Maryland-based Osiris Therapeutics focuses on the development and marketing of stem cell products to treat serious inflammatory, autoimmune, orthopedic, and cardiovascular conditions. The company’s shares are currently priced at $11.45 and are up over 38 percent over the last six months.

Pluristem (PSTI) — The Israel-based Pluristem develops stem cell therapies from placenta cells for a number of diseases, and is currently preparing for clinical trials for a Peripheral Artery Disease treatment. The company has a market cap of $173.9 million, with shares trading at $2.98, down 7 percent over the past half year.

Cytori Therapeutics (CYTX) — Cytoris Therapeutics uses adult stem cells to develop regenerative therapies for cardiovascular conditions and soft tissue defects. The US company has a market cap of $188.9 million with shares currently priced at $2.82, up 2.5 percent over the last six months.

Neostem (NBS) — The New York, NY-based Neostem owns and operates a number of subsidiaries in the stem-cell based regenerative medicine industry that develop treatments for cardiovascular, autoimmune, and inflammatory conditions. The company is nearing clinical trials for a periodontitis treatment. With a market cap of $117.7 million, shares are currently priced at $7.05, up 10 percent over the past six months, and 17 percent year-to-date.

Advanced Cell Technology ($ACTC) — The Santa Monica, CA-based Advanced Cell Technology uses both adult and embryonic stem cells to develop treatments for retinal, blood, and heart diseases, and has recently initiated two different clinical trials for degenerative retinal disease. With a market cap of $179 million, shares are currently priced at $0.07, down $0.01 over the past six months.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.

Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for cytx
30 Oct 14 02:13:41
I like $CYTX off base/strength and above .46. maybe build under .51 for .52 bust. questionable under .48
29 Oct 14 21:06:55
Prophetable: $CYTX...get ready for a nice bounce my man!!!: Prophetable http://t.co/TEJ6YENlYK
29 Oct 14 20:52:48
Prophetable: $CYTX...get ready for a nice bounce my man!!! http://t.co/lBxw5hfjjP
29 Oct 14 20:52:47
Prophetable: $CYTX...get ready for a nice bounce my man!!! http://t.co/wskUyUYiRz
29 Oct 14 20:52:46
Prophetable: $CYTX...get ready for a nice bounce my man!!! http://t.co/t3pRSg0QOc
High Octane
29 Oct 14 19:42:19
Watchlist for 10/30/2014: $HNSN, $HDSN, $LAKE, $APT, $EKSO, $RCPI, $GENE, $CYTX, $IKAN, $RGDO, $IFON
pete doom
29 Oct 14 18:29:22
RT @piggyprophet: $CYTX nice day. Looking forward to a push beyond that .51c resistance tomorrow.
29 Oct 14 13:04:01
$CYTX nice day. Looking forward to a push beyond that .51c resistance tomorrow.
Andy G
29 Oct 14 10:52:41
$CYTX hey what gives? where the pop...................
29 Oct 14 10:21:19
Ya think $CYTX has bottomed here at 0.50 from it's 3.50 high earlier this year?
pete doom
29 Oct 14 10:20:36
$cytx volume has nearly doubled in the last hour
Grant L
29 Oct 14 10:17:25
RT @AlertTrade: via #AlertTrade 5-min Candle Alert $CYTX - CYTORI THERAPEUTICS #daytrader #stocks http://t.co/VS8RO1bzXJ
Day Trade Alerts
29 Oct 14 10:08:15
via #AlertTrade 5-min Candle Alert $CYTX - CYTORI THERAPEUTICS #daytrader #stocks http://t.co/VS8RO1bzXJ
29 Oct 14 10:06:34
$CYTX http://t.co/eUJVKM1LtM This will keep a lid on the stock price all this dilution that the company has done
pete doom
29 Oct 14 10:04:32
ASK at .51 getting eaten up. $CYTX
pete doom
29 Oct 14 09:58:38
RT @NerdElert: $CYTX highs
pete doom
29 Oct 14 09:58:34
RT @biotrader4gain: $CYTX doing the same thing $BAXS did before it doubled .
29 Oct 14 09:58:02
$CYTX doing the same thing $BAXS did before it doubled .
pete doom
29 Oct 14 09:57:54
$cytx just roke .50 ! looks nice for a run!
29 Oct 14 09:57:20
$CYTX highs
29 Oct 14 09:45:01
$CYTX buyers
29 Oct 14 09:44:48
http://t.co/rCFETx8Oyc Mark: $CYTX, .49 next bounce play. Closed financing: Mark http://t.co/HgJK6Ve01z http://t.co/rCFETx8Oyc
Michael Goldberg
29 Oct 14 09:31:38
RT @TRezDoc: @zerosum24 @EliStamos $CYTX , $ACCO, $UNIS breakout coming
Doc Tony
29 Oct 14 09:27:58
@zerosum24 @EliStamos $CYTX , $ACCO, $UNIS breakout coming
29 Oct 14 08:23:18
#BIOS, POSITIONS IN $pgnx, $cris, $dara and $CYTX, all look ready to break out to upside.
Jon Vince
29 Oct 14 07:51:36
RT @NerdElert: getting long $CYTX at 48c ... @speculatore in right on cue here imo
29 Oct 14 07:51:22
In $CYTX. Looking good for a rip soon.
Bottoms Up
29 Oct 14 07:37:09
$CYTX .49-- .47--Cytori Therapeutics, Inc......Bounce Watch.......Chart http://t.co/Sh2SYfgNbF …
29 Oct 14 07:36:23
getting long $CYTX at 48c ... @speculatore in right on cue here imo
Bottoms Up
29 Oct 14 07:31:26
$CYTX .48-- .47--Cytori Therapeutics, Inc......Bounce Watch.......Chart http://t.co/Sh2SYfgNbF …
29 Oct 14 07:26:06
$CYTX clinical trial resume last week was over $2 before trial halt.
29 Oct 14 07:25:23
RT @speculatore: $CYTX .47--Cytori Therapeutics, Inc......Bounce Watch.......Chart http://t.co/Sh2SYfgNbF
29 Oct 14 07:23:15
adding more $CYTX long
Bottoms Up
29 Oct 14 07:21:51
$CYTX .47--Cytori Therapeutics, Inc......Bounce Watch.......Chart http://t.co/Sh2SYfgNbF
28 Oct 14 23:05:03
Cytori Therapeutics : Schedules Third Quarter Results Webcast http://t.co/bhgcxDHfh3 $CYTX
28 Oct 14 22:50:13
Cytori Therapeutics : Updates on Dean's Resignation http://t.co/0fhVL2xr8r $CYTX
28 Oct 14 13:31:56
$CYTX - Current Report Filing (8-k) http://t.co/iSjuVYSUeK
28 Oct 14 13:31:52
$CYTX - Current Report Filing (8-k) http://t.co/JMav2yCq9d
Stocks News&Markets
28 Oct 14 13:31:43
$CYTX - Current Report Filing (8-k) http://t.co/yQnI9qibnA
28 Oct 14 13:30:04
CYTORI THERAPEUTICS : Change in Directors or Principal Officers (form 8-K) http://t.co/yBCSRqEAsb $CYTX
28 Oct 14 13:25:26
$CYTX Cytori - 8-K (Current report filing) SEC Filing From our Stock News Alerts App
Instrumental Data
28 Oct 14 13:24:52
austin aucoin
28 Oct 14 12:41:11
sold too early on $BAXS. moved profits to $CYTX great time to load coming off 52 week low. contracts w/ gov .80 resistance1
28 Oct 14 07:12:16
$CYTX chart: http://t.co/3VUFRgXnNB
Jahi Faucette
28 Oct 14 06:14:06
28 Oct 14 06:08:27
#virtualreality headsets will be the consumer tech gadget for 2015. $CYTX investors can profit from Spectra7 $SPVNF: http://t.co/UGK1Sij9xy
27 Oct 14 18:38:07
Leading Tweets Relevant to $CYTX (Cytori Therapeutics Inc symbol CYTX) on 10/28/2014 http://t.co/BD2AoLmMnG
27 Oct 14 15:01:50
Cytori Therapeutics Inc (CYTX) Drops 6.82% on October 27 $cytx http://t.co/X3kWVuMsH5
27 Oct 14 08:37:28
added some $CYTX at $0.47 . looks oversold..
27 Oct 14 07:04:37
Cytori Therapeutics Receives “Positive” Rating from Maxim Group $CYTX http://t.co/xxsGZjeAXx
By  +Follow August 1, 2013 8:43AM



blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.